Results 201 to 210 of about 115,977 (260)

Correction to: Health-related qualify of life, angina type and coronary artery disease in patients with stable chest pain [PDF]

open access: gold, 2020
Nina Rieckmann   +60 more
openalex   +1 more source

Selatogrel: Potential to redefine timely anti‐platelet intervention

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 22, Page 5435-5452, November 2025.
Acute coronary syndrome (ACS) encompasses a number of heart diseases that cause a sudden decrease in coronary perfusion, precipitating cardiomyocyte necrosis or heightened risk thereof. This pathology is a major burden of cardiovascular disease.
Rudy N. Zalzal   +3 more
wiley   +1 more source

High‐intensity statin therapy is associated with reduced coronary inflammation on CT in patients with type 2 diabetes mellitus

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 11, Page 6395-6402, November 2025.
Abstract Aims Pericoronary adipose tissue (PCAT) attenuation, assessed by coronary computed tomography angiography (CCTA), is a biomarker of coronary inflammation. Mean PCAT attenuation ≥ −70.5 Hounsfield Units (HU) corresponds to elevated inflammation and a higher future risk of myocardial infarction.
Bryan Wu, Koen Nieman, Ryan Sandoval
wiley   +1 more source

Long‐term efficacy and safety of tirzepatide in participants with type 2 diabetes with inadequate glycaemic control on metformin and/or sulfonylurea: Post‐hoc analysis of SURPASS‐4

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 11, Page 6480-6490, November 2025.
Abstract Aim To evaluate the long‐term efficacy and safety data at 104 weeks in tirzepatide‐treated participants with type 2 diabetes who had inadequate glycaemic control on metformin and/or sulfonylurea. Materials and Methods This post‐hoc analysis was based on the SURPASS‐4 data (NCT03730662), a multicenter, Phase III trial.
Haixia Guan   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy